Format

Send to

Choose Destination
Cancer. 2018 Dec 15;124(24):4592-4596. doi: 10.1002/cncr.31681. Epub 2018 Nov 1.

Should chemotherapy plus immune checkpoint inhibition be the standard front-line therapy for patients with metastatic non-small cell lung cancer?

Author information

1
Department of Medicine (Medical Oncology), Yale School of Medicine, New Haven, Connecticut.
2
Department of Medicine (Medical Oncology) and Pharmacology, Yale School of Medicine, New Haven, Connecticut.

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center